BURLINGAME, Calif., May 22 /PRNewswire/ -- BioSeek, Inc., a leader in
applying integrated human biology systems for developing new therapeutics,
announced today the signing of a joint research collaboration agreement
with Amylin Pharmaceuticals, Inc. that will focus on the discovery and
development of novel peptide therapeutics for inflammatory conditions.
Amylin has also made a $10 million equity investment in BioSeek.
